Status:

TERMINATED

Project 1: ACHIEVE- HTN

Lead Sponsor:

Wayne State University

Conditions:

Hypertension

Undiagnosed Diseases

Eligibility:

All Genders

18-95 years

Phase:

NA

Brief Summary

This project is part of the ACHIEVE GREATER (Addressing Cardiometabolic Health Inequities by Early PreVEntion in the GREAT LakEs Region) Center (IRB 100221MP2A), the purpose of which is to reduce card...

Detailed Description

Hypertension (HTN) is the leading risk factor for global morbidity and mortality, accounting for a significant proportion of atherosclerotic cardiovascular disease (CVD), heart failure and chronic kid...

Eligibility Criteria

Inclusion

  • In order to be eligible to participate in this study, an individual must meet all of the following criteria:
  • Self-identified Black/African Americans
  • Detroit-area residents (defined as those who attend attended a Detroit-area community event)
  • \> 18 years of age
  • Screening systolic BP 130-139 and diastolic BP \< 90 mm Hg
  • Not currently taking medications for HTN (Untreated)
  • 10-year cardiovascular risk \< 10% per ASCVD calculator (as such nearly all patients will be \<50-55 years of age)
  • Baseline home systolic BP 120-159 mm Hg and diastolic BP \< 100 mm Hg

Exclusion

  • An individual who meets any of the following criteria will be excluded from participation in this study:
  • History of clinical cardiovascular disease (CVD)
  • History of kidney disease or eGFR \<60 mL/min from screening labs
  • Self-reported pregnancy (or planning to be pregnant in the next year)
  • History of diabetes or HbA1c \> 6.5% from SOC screening labs
  • Non-HDL-C \> 220 mg/dL from SOC labs (potential genetic hyperlipidemia)
  • Arm circumference \> 18'' (home BP arm cuff will be inaccurate)
  • Baseline home BP average \> 160mm Hg systolic and/or \>100 mm Hg diastolic

Key Trial Info

Start Date :

November 18 2022

Trial Type :

INTERVENTIONAL

Allocation :

ACTUAL

End Date :

January 25 2024

Estimated Enrollment :

8 Patients enrolled

Trial Details

Trial ID

NCT05295758

Start Date

November 18 2022

End Date

January 25 2024

Last Update

June 10 2024

Active Locations (1)

Enter a location and click search to find clinical trials sorted by distance.

Page 1 of 1 (1 locations)

1

Wayne State

Detroit, Michigan, United States, 48202